283 related articles for article (PubMed ID: 22386248)
1. Gut feelings about diabetes.
Laferrère B
Endocrinol Nutr; 2012 Apr; 59(4):254-60. PubMed ID: 22386248
[TBL] [Abstract][Full Text] [Related]
2. Effects of various gastrointestinal procedures on β-cell function in obesity and type 2 diabetes.
Malin SK; Kashyap SR
Surg Obes Relat Dis; 2016 Jul; 12(6):1213-9. PubMed ID: 27568472
[TBL] [Abstract][Full Text] [Related]
3. Incretin hormones: Their role in health and disease.
Nauck MA; Meier JJ
Diabetes Obes Metab; 2018 Feb; 20 Suppl 1():5-21. PubMed ID: 29364588
[TBL] [Abstract][Full Text] [Related]
4. Diabetes remission after bariatric surgery: is it just the incretins?
Laferrère B
Int J Obes (Lond); 2011 Sep; 35 Suppl 3(0 3):S22-5. PubMed ID: 21912382
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of Diabetes Improvement Following Bariatric/Metabolic Surgery.
Batterham RL; Cummings DE
Diabetes Care; 2016 Jun; 39(6):893-901. PubMed ID: 27222547
[TBL] [Abstract][Full Text] [Related]
6. Bariatric surgery and T2DM improvement mechanisms: a mathematical model.
Toghaw P; Matone A; Lenbury Y; De Gaetano A
Theor Biol Med Model; 2012 May; 9():16. PubMed ID: 22587410
[TBL] [Abstract][Full Text] [Related]
7. Bariatric surgery and type 2 diabetes: are there weight loss-independent therapeutic effects of upper gastrointestinal bypass?
Chondronikola M; Harris LL; Klein S
J Intern Med; 2016 Nov; 280(5):476-486. PubMed ID: 27739136
[TBL] [Abstract][Full Text] [Related]
8. Do we really know why diabetes remits after gastric bypass surgery?
Laferrère B
Endocrine; 2011 Oct; 40(2):162-7. PubMed ID: 21853297
[TBL] [Abstract][Full Text] [Related]
9. Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss.
Gumbs AA; Modlin IM; Ballantyne GH
Obes Surg; 2005 Apr; 15(4):462-73. PubMed ID: 15946423
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms in bariatric surgery: Gut hormones, diabetes resolution, and weight loss.
Holst JJ; Madsbad S; Bojsen-Møller KN; Svane MS; Jørgensen NB; Dirksen C; Martinussen C
Surg Obes Relat Dis; 2018 May; 14(5):708-714. PubMed ID: 29776493
[TBL] [Abstract][Full Text] [Related]
11. The emerging role of the intestine in metabolic diseases.
Bradley WD; Zwingelstein C; Rondinone CM
Arch Physiol Biochem; 2011 Jul; 117(3):165-76. PubMed ID: 21671708
[TBL] [Abstract][Full Text] [Related]
12. Roux-en-Y gastric bypass versus calorie restriction: support for surgery per se as the direct contributor to altered responses of insulin and incretins to a mixed meal.
Berggren J; Lindqvist A; Hedenbro J; Groop L; Wierup N
Surg Obes Relat Dis; 2017 Feb; 13(2):234-242. PubMed ID: 27894746
[TBL] [Abstract][Full Text] [Related]
13. Role of the incretin system in the remission of type 2 diabetes following bariatric surgery.
Mingrone G
Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):574-9. PubMed ID: 18790374
[TBL] [Abstract][Full Text] [Related]
14. [Early improvement in Type 2 diabetes in obese patients following gastric bypass and bilio-pancreatic diversion: the role of the entero-insular axis].
Lifante JC; Inabnet WB
J Chir (Paris); 2008; 145(6):549-55. PubMed ID: 19106885
[TBL] [Abstract][Full Text] [Related]
15. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes.
Laferrère B; Teixeira J; McGinty J; Tran H; Egger JR; Colarusso A; Kovack B; Bawa B; Koshy N; Lee H; Yapp K; Olivan B
J Clin Endocrinol Metab; 2008 Jul; 93(7):2479-85. PubMed ID: 18430778
[TBL] [Abstract][Full Text] [Related]
16. Glucose Metabolism After Gastric Banding and Gastric Bypass in Individuals With Type 2 Diabetes: Weight Loss Effect.
Holter MM; Dutia R; Stano SM; Prigeon RL; Homel P; McGinty JJ; Belsley SJ; Ren CJ; Rosen D; Laferrère B
Diabetes Care; 2017 Jan; 40(1):7-15. PubMed ID: 27999001
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of early improvement/resolution of type 2 diabetes after bariatric surgery.
Mingrone G; Castagneto-Gissey L
Diabetes Metab; 2009 Dec; 35(6 Pt 2):518-23. PubMed ID: 20152737
[TBL] [Abstract][Full Text] [Related]
18. The incretin system ABCs in obesity and diabetes - novel therapeutic strategies for weight loss and beyond.
João AL; Reis F; Fernandes R
Obes Rev; 2016 Jul; 17(7):553-72. PubMed ID: 27125902
[TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal dopamine as an anti-incretin and its possible role in bypass surgery as therapy for type 2 diabetes with associated obesity.
Chaudhry S; Bernardes M; Harris PE; Maffei A
Minerva Endocrinol; 2016 Mar; 41(1):43-56. PubMed ID: 26505694
[TBL] [Abstract][Full Text] [Related]
20. The role of bariatric surgery to treat diabetes: current challenges and perspectives.
Koliaki C; Liatis S; le Roux CW; Kokkinos A
BMC Endocr Disord; 2017 Aug; 17(1):50. PubMed ID: 28797248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
